位置:首页 > 蛋白库 > MBCT_MYCTU
MBCT_MYCTU
ID   MBCT_MYCTU              Reviewed;         186 AA.
AC   P9WLP9; L0TB64; P64907; Q10869;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   03-AUG-2022, entry version 33.
DE   RecName: Full=NAD(+) phosphorylase MbcT {ECO:0000303|PubMed:30792174};
DE            EC=2.4.2.- {ECO:0000269|PubMed:30792174};
DE   AltName: Full=Mycobacterial cidal toxin MbcT {ECO:0000303|PubMed:30792174};
DE   AltName: Full=Toxin Res {ECO:0000303|PubMed:30315706};
DE   AltName: Full=ucAT8 toxin {ECO:0000303|PubMed:28724903};
GN   Name=mbcT {ECO:0000303|PubMed:30792174}; OrderedLocusNames=Rv1989c;
GN   ORFNames=MTCY39.30;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [2]
RP   INDUCTION BY HYPOXIA.
RC   STRAIN=ATCC 27294 / TMC 102 / H37Rv;
RX   PubMed=18231589; DOI=10.1371/journal.pone.0001502;
RA   Rustad T.R., Harrell M.I., Liao R., Sherman D.R.;
RT   "The enduring hypoxic response of Mycobacterium tuberculosis.";
RL   PLoS ONE 3:E1502-E1502(2008).
RN   [3]
RP   INDUCTION IN MOUSE INFECTION MODEL.
RC   STRAIN=H37Rv;
RX   PubMed=20628579; DOI=10.1371/journal.ppat.1000988;
RA   Homolka S., Niemann S., Russell D.G., Rohde K.H.;
RT   "Functional genetic diversity among Mycobacterium tuberculosis complex
RT   clinical isolates: delineation of conserved core and lineage-specific
RT   transcriptomes during intracellular survival.";
RL   PLoS Pathog. 6:E1000988-E1000988(2010).
RN   [4]
RP   INDUCTION BY HYPOXIA AND IN PERSISTER CELLS.
RC   STRAIN=H37Rv;
RX   PubMed=21673191; DOI=10.1128/mbio.00100-11;
RA   Keren I., Minami S., Rubin E., Lewis K.;
RT   "Characterization and transcriptome analysis of Mycobacterium tuberculosis
RT   persisters.";
RL   MBio 2:E00100-E00111(2011).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=28096490; DOI=10.1128/mbio.02133-16;
RA   DeJesus M.A., Gerrick E.R., Xu W., Park S.W., Long J.E., Boutte C.C.,
RA   Rubin E.J., Schnappinger D., Ehrt S., Fortune S.M., Sassetti C.M.,
RA   Ioerger T.R.;
RT   "Comprehensive essentiality analysis of the Mycobacterium tuberculosis
RT   genome via saturating transposon mutagenesis.";
RL   MBio 8:0-0(2017).
RN   [7]
RP   INDUCTION BY STRESS.
RC   STRAIN=H37Rv;
RX   PubMed=28724903; DOI=10.1038/s41598-017-06003-7;
RA   Gupta A., Venkataraman B., Vasudevan M., Gopinath Bankar K.;
RT   "Co-expression network analysis of toxin-antitoxin loci in Mycobacterium
RT   tuberculosis reveals key modulators of cellular stress.";
RL   Sci. Rep. 7:5868-5868(2017).
RN   [8]
RP   FUNCTION AS A TOXIN, AND EXPRESSION IN E.COLI.
RC   STRAIN=H37Rv;
RX   PubMed=30315706; DOI=10.1111/mmi.14150;
RA   Skjerning R.B., Senissar M., Winther K.S., Gerdes K., Brodersen D.E.;
RT   "The RES domain toxins of RES-Xre toxin-antitoxin modules induce cell
RT   stasis by degrading NAD+.";
RL   Mol. Microbiol. 111:221-236(2019).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 2-186 IN COMPLEX WITH ANTITOXIN,
RP   FUNCTION AS A TOXIN, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBUNIT, INDUCTION BY STARVATION, DISRUPTION PHENOTYPE, BIOTECHNOLOGY, AND
RP   MUTAGENESIS OF ARG-27; TYR-28; ARG-47; TYR-58; GLU-69 AND SER-126.
RC   STRAIN=ATCC 27294 / TMC 102 / H37Rv;
RX   PubMed=30792174; DOI=10.1016/j.molcel.2019.01.028;
RA   Freire D.M., Gutierrez C., Garza-Garcia A., Grabowska A.D., Sala A.J.,
RA   Ariyachaokun K., Panikova T., Beckham K.S.H., Colom A., Pogenberg V.,
RA   Cianci M., Tuukkanen A., Boudehen Y.M., Peixoto A., Botella L.,
RA   Svergun D.I., Schnappinger D., Schneider T.R., Genevaux P.,
RA   de Carvalho L.P.S., Wilmanns M., Parret A.H.A., Neyrolles O.;
RT   "An NAD+ phosphorylase toxin triggers Mycobacterium tuberculosis cell
RT   death.";
RL   Mol. Cell 73:1282-1291(2019).
CC   -!- FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system.
CC       Neutralized by cognate antitoxin MbcA (PubMed:30315706,
CC       PubMed:30792174). Degrades NAD(+) by phosphorolysis. Expression in the
CC       absence of its cognate antitoxin MbcA causes dramatic reduction of
CC       intracellular NAD(+) levels and is deleterious to cell growth, causing
CC       cell death. In a SCID mouse infection model, mice infected with
CC       bacteria overexpressing this protein survive longer. Overexpression of
CC       this protein in a mouse infection model at 21 days leads to bacterial
CC       death, and shows a synergistic 100-fold increase in mouse survival when
CC       combined with isoniazid treatment (PubMed:30792174).
CC       {ECO:0000269|PubMed:30315706, ECO:0000269|PubMed:30792174}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + phosphate = ADP-beta-D-ribose 1''-phosphate + H(+) +
CC         nicotinamide; Xref=Rhea:RHEA:20788, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:43474, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:58753; Evidence={ECO:0000269|PubMed:30792174};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=110 uM for NAD(+) {ECO:0000269|PubMed:30792174};
CC         Note=kcat for NAD(+) is 167 sec(-1). {ECO:0000269|PubMed:30792174};
CC   -!- SUBUNIT: Heterotetramer with 2 subunits each of MbcT and MbcA; the
CC       tetramers further assemble into trimers with 3-fold symmetry. The
CC       antitoxin acts by blocking acces to the toxin active site.
CC       {ECO:0000269|PubMed:30792174}.
CC   -!- INDUCTION: Induced by hypoxia (PubMed:18231589). Expression induced in
CC       both active and resting C57BL/6 mouse macrophages (PubMed:20628579).
CC       Induced in persister cells (PubMed:21673191). Induced by streptomycin
CC       treatment and by starvation (PubMed:28724903). Induced by starvation
CC       stress; probably part of the mbcT-mbcA operon (PubMed:30792174).
CC       {ECO:0000269|PubMed:18231589, ECO:0000269|PubMed:20628579,
CC       ECO:0000269|PubMed:21673191, ECO:0000269|PubMed:28724903,
CC       ECO:0000269|PubMed:30792174}.
CC   -!- DISRUPTION PHENOTYPE: Not essential, it can be deleted
CC       (PubMed:28096490). Deletion of the mbcT-mbcA operon has no visible
CC       phenotype (PubMed:30792174). {ECO:0000269|PubMed:28096490,
CC       ECO:0000269|PubMed:30792174}.
CC   -!- BIOTECHNOLOGY: Molecules that disrupt the MbcT-MbcA complex could be
CC       candidates for anti-tuberculosis therapy.
CC       {ECO:0000269|PubMed:30792174}.
CC   -!- SIMILARITY: Belongs to the MbcT/ParT/Res family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP44759.1; -; Genomic_DNA.
DR   PIR; C70757; C70757.
DR   RefSeq; NP_216505.1; NC_000962.3.
DR   RefSeq; WP_003410001.1; NZ_NVQJ01000043.1.
DR   PDB; 6FKG; X-ray; 1.80 A; A/B=2-186.
DR   PDBsum; 6FKG; -.
DR   AlphaFoldDB; P9WLP9; -.
DR   SASBDB; P9WLP9; -.
DR   SMR; P9WLP9; -.
DR   STRING; 83332.Rv1989c; -.
DR   PaxDb; P9WLP9; -.
DR   DNASU; 885810; -.
DR   GeneID; 885810; -.
DR   KEGG; mtu:Rv1989c; -.
DR   TubercuList; Rv1989c; -.
DR   eggNOG; COG5654; Bacteria.
DR   OMA; DSTRACM; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0016779; F:nucleotidyltransferase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR014914; RES_dom.
DR   Pfam; PF08808; RES; 1.
DR   SMART; SM00953; RES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; NAD; Nucleotidyltransferase; Reference proteome;
KW   Toxin-antitoxin system; Transferase.
FT   CHAIN           1..186
FT                   /note="NAD(+) phosphorylase MbcT"
FT                   /id="PRO_0000103918"
FT   MUTAGEN         27
FT                   /note="R->A: No longer toxic."
FT                   /evidence="ECO:0000269|PubMed:30792174"
FT   MUTAGEN         27
FT                   /note="R->E: No longer toxic, does not degrade NAD(+)."
FT                   /evidence="ECO:0000269|PubMed:30792174"
FT   MUTAGEN         28
FT                   /note="Y->A: Reduced toxicity."
FT                   /evidence="ECO:0000269|PubMed:30792174"
FT   MUTAGEN         47
FT                   /note="R->A: No longer toxic."
FT                   /evidence="ECO:0000269|PubMed:30792174"
FT   MUTAGEN         58
FT                   /note="Y->A: No longer toxic."
FT                   /evidence="ECO:0000269|PubMed:30792174"
FT   MUTAGEN         69
FT                   /note="E->A: Reduced toxicity."
FT                   /evidence="ECO:0000269|PubMed:30792174"
FT   MUTAGEN         126
FT                   /note="S->A: No change in toxicity."
FT                   /evidence="ECO:0000269|PubMed:30792174"
FT   HELIX           7..16
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   STRAND          19..30
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           39..44
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   STRAND          56..62
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           63..76
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           81..84
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   STRAND          89..103
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           107..112
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           117..121
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           126..137
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   STRAND          142..147
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   STRAND          150..157
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           158..161
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   STRAND          166..174
FT                   /evidence="ECO:0007829|PDB:6FKG"
FT   HELIX           177..184
FT                   /evidence="ECO:0007829|PDB:6FKG"
SQ   SEQUENCE   186 AA;  20281 MW;  8414F65A43BD909D CRC64;
     MSDALDEGLV QRIDARGTIE WSETCYRYTG AHRDALSGEG ARRFGGRWNP PLLFPAIYLA
     DSAQACMVEV ERAAQAASTT AEKMLEAAYR LHTIDVTDLA VLDLTTPQAR EAVGLENDDI
     YGDDWSGCQA VGHAAWFLHM QGVLVPAAGG VGLVVTAYEQ RTRPGQLQLR QSVDLTPALY
     QELRAT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024